gadolinium dtpa has been researched along with Hyperlipoproteinemia Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fitzpatrick, J; Hajnal, JV; Naoumova, RP; Neuwirth, C; O'Regan, DP; Potter, E; Schmitz, SA; Tosi, I | 1 |
1 other study(ies) available for gadolinium dtpa and Hyperlipoproteinemia Type II
Article | Year |
---|---|
White matter brain lesions in midlife familial hypercholesterolemic patients at 3-Tesla magnetic resonance imaging.
Topics: Adult; Age Factors; Body Mass Index; Brain; Brain Diseases; Cholesterol; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Observer Variation; Risk Assessment; Risk Factors | 2008 |